Whole-body deletion of LPS-induced TNF-α factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 52, 2011, Pages 21247-21252

  Merrill, Jamie C ^a   You, Jian ^a   Constable, Cara ^a   Leeman, Susan E ^b   Amar, Salomon ^a  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Multiplex; Septic shock

Indexed keywords

COLLAGEN; CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE INDUCED TUMOR NECROSIS ALPHA FACTOR; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; INFLAMMATION; INFLAMMATORY DISEASE; MACROPHAGE; MEDIATOR; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL RATE; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BLOTTING, WESTERN; CROSSES, GENETIC; CYTOKINES; DNA PRIMERS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; SHOCK, SEPTIC; TAMOXIFEN; TRANSCRIPTION FACTORS;

ESCHERICHIA COLI; MUS;

EID: 84855513539     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1111492108     Document Type: Article

References (34)

1. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE (2007) Chronic inflammation: Importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 147:227-235. (Pubitemid 46095999)
2. Hunt TK, Knighton DR, Thakral KK, Goodson WH, III, Andrews WS (1984) Studies on inflammation and wound healing: Angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. Surgery 96(1):48-54. (Pubitemid 14094943)
3. Remick DG, Kunkel SL (1993) Pathophysiologic alterations induced by tumor necrosis factor. Int Rev Exp Pathol 34(Pt B):7-25.
4. Neale ML, Williams BD, Matthews N (1989) Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol 28(4):104-108. (Pubitemid 19117054)
5. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356-361.
6. Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397-440. (Pubitemid 26130190)
7. Matera MG, Calzetta L, Cazzola M (2010) TNF-alpha inhibitors in asthma and COPD: We must not throw the baby out with the bath water. Pulm Pharmacol Ther 23(2): 121-128.
8. Dahlström U (2005) Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 7:309-316.
9. Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50: 1740-1751. (Pubitemid 38725085)
10. Nakelchik M, Mangino JE (2002) Reactivation of histoplasmosis after treatment with infliximab. Am J Med 112:78.
11. Myokai F, Takashiba S, Lebo R, Amar S (1999) A novel lipopolysaccharide- induced transcription factor regulating tumor necrosis factor alpha gene expression: Molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci USA 96:4518-4523. (Pubitemid 29190368)
12. Tang X, Fenton MJ, Amar S (2003) Identification and functional characterization of a novel binding site on TNF-alpha promoter. Proc Natl Acad Sci USA 100:4096-4101. (Pubitemid 36418163)
13. Srinivasan S, Leeman SE, Amar S (2010) Beneficial dysregulation of the time course of inflammatory mediators in lipopolysaccharide-induced tumor necrosis factor alpha factor-deficient mice. Clin Vaccine Immunol 17:699-704.
14. Tang X, Marciano DL, Leeman SE, Amar S (2005) LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci USA 102:5132-5137.
15. Tang X, Metzger D, Leeman S, Amar S (2006) LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways. Proc Natl Acad Sci USA 103:13777-13782. (Pubitemid 44413984)
16. Silverstein R (2004) D-galactosamine lethality model: Scope and limitations. J Endotoxin Res 10:147-162.
17. Lehmann V, Freudenberg MA, Galanos C (1987) Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine- treated mice. J Exp Med 165:657-663. (Pubitemid 17059444)
18. Armaka M, et al. (2008) Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med 205: 331-337. (Pubitemid 351281599)
19. Mignon A, et al. (1999) LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med 159:1308-1315. (Pubitemid 29202572)
20. Marino MW, et al. (1997) Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 94:8093-8098. (Pubitemid 27343782)
21. Wipke BT, Allen PM (2001) Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 167:1601-1608. (Pubitemid 32703161)
22. Osuchowski MF, Welch K, Siddiqui J, Remick DG (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177:1967-1974. (Pubitemid 44092537)
23. Khachigian LM (2006) Collagen antibody-induced arthritis. Nat Protoc 1:2512-2516.
24. Terato K, et al. (1992) Induction of arthritis with monoclonal antibodies to collagen. J Immunol 148:2103-2108.
25. Fridman JS, et al. (2010) Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: Preclinical characterization of INCB028050. J Immunol 184: 5298-5307.
26. Maini RN, et al. (1998) Therapeutic efficacy of multiple intravenous infusions of antitumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41:1552-1563. (Pubitemid 28459913)
27. Deng GM, Zheng L, Chan FK, Lenardo M (2005) Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat Med 11:1066-1072. (Pubitemid 41486828)
28. Kawane K, Tanaka H, Kitahara Y, Shimaoka S, Nagata S (2010) Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation. Proc Natl Acad Sci USA 107:19432-19437.
29. Maia M, et al. (2010) CD248 and its cytoplasmic domain: A therapeutic target for arthritis. Arthritis Rheum 62:3595-3606.
30. Fei Y, et al. (2011) The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice. J Infect Dis 204(3):348-357.
31. Tang X, Molina M, Amar S (2007) p53 short peptide (p53pep164) regulates lipopolysaccharide- induced tumor necrosis factor-alpha factor/cytokine expression. Cancer Res 67:1308-1316.
32. Tang X, et al. (2011) p53 peptide prevents LITAF-induced TNF-alpha-mediated mouse lung lesions and endotoxic shock. Curr Mol Med 11:439-452.
33. Zhou J, et al. (2011) LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth. Oncogene 30:1892-1900.
34. Pollastri MP, et al. (2009) Identification and characterization of kava-derived compounds mediating TNF-alpha suppression. Chem Biol Drug Des 74(2):121-128.